Bone morphogenetic protein 15 (BMP15) and growth and differentiation factor 9 (GDF9) are secreted by the mammalian oocyte and are essential for ovarian follicular development, ovulation, and fertility. However, the secreted forms of the BMP15 and GDF9 proteins and the nature of cooperative molecular interactions between BMP15 and GDF9 previously reported have not been fully characterized. In this study, we found that recombinant mouse BMP15 and GDF9 are secreted as cleaved mature and proregion proteins, with BMP15 also secreted as uncleaved promature protein. Noncovalent interactions were identified between the mature and proregion proteins of each growth factor. Moreover, GDF9 mature protein was found to coimmunoprecipitate with the BMP15 proregion, suggestive of a heteromeric association between BMP15 and GDF9. Mouse GDF9 was found to exist mostly as a dimer of mature protein, in both the presence and absence of BMP15. In contrast, BMP15 formed mostly multimers of proregion and mature protein when combined with GDF9, providing further evidence for heteromeric interaction. Mouse BMP15 was found to act cooperatively with GDF9 in a rat granulosa cell thymidine incorporation bioassay and to signal through the BMPR2 and ACVR1B/TGFBR1/ACVR1C receptor-mediated pathways. Immunoneutralization experiments using GDF9 mature protein antibody indicated that these cooperative interactions are species specific. Additionally, immunoneutralization with proregion antibodies highlighted the involvement of the BMP15 proregion in BMP15/GDF9 cooperative interactions. Taken together, these findings support a novel hypothesis where the extracellular cooperative interactions of recombinant mouse BMP15 and GDF9 are multimeric, involving the proregion of BMP15, and may well be species specific.
INTRODUCTION
Bone morphogenetic protein 15 (BMP15) and growth and differentiation factor 9 (GDF9) are oocyte-derived proteins known to be essential for ovarian follicular development, ovulation, and fertility [1] [2] [3] [4] [5] [6] [7] . The initiation of BMP15 and GDF9 expression occurs during early follicular development in either primordial or primary follicles, depending on the species [8] . However, in the mouse it has been reported that BMP15 protein expression may not occur until immediately before ovulation [9] . Phenotypes of animals with altered BMP15 or GDF9 levels, such as mice lacking active Bmp15 or Gdf 9 genes [10, 11] , sheep immunized with BMP15 or GDF9 peptides, or sheep with naturally occurring mutations inactivating BMP15 or GDF9 [12] [13] [14] [15] , provide evidence for species differences in the dose requirements for BMP15 and GDF9. Additionally, in vitro experiments have also shown that the bioactivity of BMP15 or GDF9 depends on the species of origin of both the growth factor protein and the granulosa cells being studied [16, 17] .
BMP15, GDF9, and BMP6 belong to an oocyte-secreted subgroup of the TGF-beta superfamily of proteins [8, 18, 19] . Currently, more than 40 members of this TGF-beta superfamily have been identified and are known to be translated as pre-promature proteins that are processed enzymatically after dimerization. The protein dimers are then secreted in forms that mostly have not been characterized, in order to bind to target receptors and to signal via Smad and other pathways for downstream regulation of gene transcription [20, 21] . BMP15, GDF9, GDF3, LEFTY1, and LEFTY2 are part of a subset of TGF-beta proteins that lack the cysteine in the mature protein responsible for dimeric covalent bonding [2] . Instead, BMP15 and GDF9 may exist as monomers, or as non-covalently associated homo-or heterodimers as has been observed in vitro [22] . The plasma membrane receptors for BMP15 have been identified as the type 1 receptor BMPR1B (also known as ALK6) and type 2 receptor BMPR2, activating the Smad 1/5/8 and ERK1/2 signaling pathways [23] . GDF9 is reported to signal through TGFBR1 and BMPR2 [24, 25] via the Smad 2/3 pathway [26] .
In mice, BMP15 and GDF9 are known to act synergistically to affect fertility. This was evident in a Bmp15 À/À Gdf 9 þ/À double mutation having more severe effects than either of the two individual mutations alone [27, 28] . In addition, our group reported a cooperativity between BMP15 and GDF9 for mitogenic and steroidogenic bioactivity in granulosa cells of several species [16, 17] . Details of molecular mechanisms underlying cooperative bioactivity between BMP15 and GDF9 are not yet known but potentially involve other binding proteins, homo-or heterodimerization of BMP15 and GDF9 mature regions, and/or interaction with BMP15 and GDF9 proregions, either before or during receptor binding. Regulation by the proregion has been identified for several TGF-beta family proteins [29] [30] [31] [32] [33] . Moreover, mutations in the human BMP15 and GDF9 proregions that lead to premature ovarian failure [34] [35] [36] or dizygotic twinning [37] emphasize the importance of BMP15 and GDF9 proregions in human fertility.
Previously it has been suggested that posttranslational processing of BMP15 is species dependent, whereby mouse BMP15 acts intracellularly to aid processing of GDF9 but is not secreted from the cell [22, 38, 39] . Additionally, reports of a differential BMP15 expression in mice compared with other species have led to the speculation that BMP15 is key to the species-dependent ovulation quota [9] . The present study investigated the protein forms of recombinant mouse BMP15 and GDF9 secreted by 293H cells and the involvement of these forms in BMP15/GDF9 cooperative bioactivity. In particular, we wanted to determine if there are species differences in these cooperative interactions and if the proregions of BMP15 and GDF9 might have extracellular roles that are regulatory.
MATERIALS AND METHODS
All animal immunization and tissue recovery protocols outlined below were performed with approval of the Animal Ethics Committee of the Wallaceville Animal Research Centre, Upper Hutt, in accordance with the 1999 Animal Welfare Act (Part 6), New Zealand.
Construction of Expression Plasmids
To generate recombinant mouse BMP15 and GDF9, cDNA containing fulllength sequences was amplified by RT-PCR from mouse ovarian RNA (primers for Bmp15 (AF082348): 5 0 ccgctcgaggctttgcaagatggcccttctc3 0 , 5 0 gctctagactattatctacatgtacag3 0 ; primers for Gdf 9 (NM_008110):
. The PCR products were cloned into pGEMTeasy then sub-cloned into the mammalian expression plasmid pEFIRES [40] using Xho1/Xba1 sites for Bmp15 and EcoRI/Xba1 sites for Gdf 9.
Production and Analysis of Secreted Forms of Recombinant Proteins
293H cells (human embryonic kidney cell-line, gifted by Prof. O. Ritvos, University of Helsinki, Finland) were transfected as previously reported [17] , using the transfection reagent Lipofectamine 2000 (Invitrogen). Transfected cells were selected by resistance to puromycin (up to 100 lg/ml) during culture in Dulbecco modified Eagle medium (DMEM) high glucose with 10% fetal calf serum, 100 units/ml penicillin, 100 mg/ml streptomycin (all from Invitrogen), and 2 mM L-glutamate (Sigma). Conditioned media (CM) were collected after 3.5 days of incubation in expression media (50% DMEM with 50% Hams F12 [Invitrogen], 100 units/ml penicillin, 100 mg/ml streptomycin, 2 mM Lglutamate, 0.01% BSA [Sigma] , and 100 lg/ml heparin [Sigma]). Western blotting analysis was carried out by electrophoresis on 13.5% SDSpolyacrylamide gels under reducing conditions, immunoblotting to nitrocellulose membrane, and chemiluminescent detection. Detection antibodies included monoclonal antibody 37A (mab37A; 1 mg/ml) made against full-length E. coliproduced ovine GDF9 mature protein, and mouse polyclonal antisera (1/6000 dilution) from mice immunized with proregion or mature-region peptides conjugated to keyhole limpet hemocyanin (KLH). Peptides unconjugated and conjugated to KLH were purchased from Global Peptide (mouse BMP15 mature peptide SDASCPSQEHDGSVN; mouse BMP15 proregion peptide A D D P T L P S I L D L A K E A P G ; m o u s e G D F 9 p r o r e g i o n p e p t i d e PVDGTDRSGLLPPLFKVL). To generate antisera, 3-mo-old CF1 female mice were immunized (i.p.) with a total of 0.4 mg peptide in Freund complete adjuvant over 6 wk. Secondary antibody anti-mouse horseradish peroxidase (1/ 6000 dilution) was purchased from Jackson ImmunoResearch Europe Ltd. The proregion or mature proteins of BMP15 and GDF9 were produced in E. coli and used for quantitation of recombinant proteins in CM. Both E. coli and mammalian recombinant proregion proteins were used as antigens to confirm the sensitivity and non-cross-reactivity of each antibody in Western blotting. To further validate antibody specificity, prior to immunoblotting the antisera were each preabsorbed overnight with the appropriate unconjugated immunization peptide, while mab37A was blocked with E. coli-produced ovine GDF9 mature protein. Immunoprecipitation was performed by incubating CM with purified IgG antibodies (0.5 mg/ml) for 2 h at 48C prior to addition of 25 ll protein-G Sepharose 4B beads (Amersham Biosciences). Purified IgG antibodies were produced from sera of sheep immunized with the mouse proregion peptides as detailed above, using ammonium sulfate precipitation and MEP hypercell column chromatography. The specificity of proregion IgG antibodies was validated prior to immunoprecipitation and immunoneutralization experiments by confirming a) antibody recognition of the appropriate E. coli and mammalian recombinant proregion proteins, b) non-cross-reactivity of BMP15 antigens with GDF9 antibodies and of GDF9 with BMP15 antibodies, and c) immunoprecipitation of the specific proregion by the IgG and protein-G Sepharose. For chemical cross-linking, the noncleavable cross-linker bissulfosuccinimidyl suberate (BS3; Pierce) was added (2 mM) to CM containing similar concentrations of BMP15 or GDF9 and incubated on ice for 2 h prior to Western immunoblotting.
Rat Granulosa Cell Thymidine Incorporation Bioassay
Rat granulosa cells were collected for 3 H-thymidine incorporation bioassays as previously described [17] . Treatments included mouse or ovine BMP15 (6 ng/ml) and GDF9 (25 ng/ml) with a total of 8% (v/v) 293H media in any one treatment. For immunoneutralization, IgG antibodies (0.5 mg/ml) as detailed above were incubated with CM at 48C for 2 h prior to the thymidine uptake bioassay. Monoclonal antibody 47B (mab47B; 0.5 lg/ml), made against the GDF9 mature protein sequence SEYFKQFLFPQNEC, was added immediately before bioassay. This antibody had previously been tested for specific recognition of mouse and ovine recombinant GDF9 mature proteins produced in E. coli and 293H cells, and no cross-reactivity with BMP15 from either species was noted. To elucidate the receptor-mediated signaling pathway, we added immediately prior to the bioassay either the human BMPR2 extracellular domain (ECD) fused to the IgG Fc region with human homodimeric IgG Fc protein as a control (3 lg/ml; R&D Systems), or the ACVR1B/TGFBR1/ACVR1C receptor inhibitor SB431542 (1 lM; TOCRIS BioScience) with Activin A (10 ng/ml) and BMP4 (30 ng/ml; both human growth factors from R&D Systems) as positive and negative controls, respectively. All treatments were performed at least in triplicate, with a minimum of three independent pools (range 3-7) of granulosa cells being tested. Statistical differences between treatments and controls were determined using General Linear Models (GLM) with Tukey studentized range post-hoc test on log-transformed data, with replicate included in the model. All values were converted to a ratio (6SEM) over the activity of cells treated with 293H control CM, which was assigned a value of 1.00.
RESULTS

Secreted Forms of Recombinant Mouse BMP15 and GDF9
From transfected 293H cells, CM was collected as several batches and analyzed by Western blotting using antibodies shown to be sensitive and specific. We found that mouse BMP15 was secreted into CM as a 24 M r 3 10 À3 mature protein and as a 28 M r 3 10 À3 protein that may be a differentially glycosylated mature protein (Fig. 1A) . Additionally, BMP15 was also secreted as a cleaved proregion (40 M r 3 10 À3 ) and as an uncleaved promature protein (55-58 M r 3 10 À3 ). Mouse GDF9 was secreted into CM as a mature protein of 20 M r 3 10 À3 , as found by others [41] , and as a cleaved proregion protein (42M r 3 10 À3 ), with no evidence for the presence of uncleaved promature GDF9 (Fig. 1B) .
Proregion and Mature Region Proteins Participate in Hetero-Multimeric Complexes
Noncovalent interactions between mouse proregion and mature proteins in CM containing either BMP15 or GDF9, or both BMP15 and GDF9, were investigated by coimmunoprecipitation in five repeat experiments ( Fig. 2A) . Mouse BMP15 mature region coimmunoprecipitated with BMP15 proregion, with or without GDF9 CM ( Fig. 2A, top panel, lanes 16 and 8) . Likewise, GDF9 mature protein precipitated with GDF9 proregion with or without BMP15 ( Fig. 2A, bottom panel,  lanes 15 and 11) . Additionally, GDF9 mature protein coimmunoprecipitated with the BMP15 proregion antibody when BMP15 and GDF9 were both present ( Fig. 2A, bottom  panel, lane 16 ). Bands showing precipitation between GDF9 and antibodies for anti-KLH and for BMP15 proregion when only GDF9 CM was present were indicative of some nonspecific interaction occurring between GDF9 and IgG proteins ( Fig. 2A, bottom panel, lanes 10 and 12) . Evidence for incompletely stripped BMP15 was also observed in lane 8 of the anti-GDF9 blot ( Fig. 2A, bottom panel) .
890
Chemical cross-linking was performed for further visualization of noncovalent interactions (Fig. 2B) . When crosslinked in the absence of GDF9, BMP15 was observed as mature, promature, and proregion monomers and multimers, with no evidence of mature protein dimers (Fig. 2B, top panel) . In contrast, GDF9 predominantly formed mature protein homodimers with or without BMP15, with some multimers of GDF9 that potentially included the proregions of GDF9 and of BMP15 (Fig. 2B, bottom panel) . A nonspecific 66 M r 3 10 À3 band that was usually not visible on BMP15 mature antibody immunoblots of BMP15 CM alone, but observed with other antibodies, became visible when GDF9 and BMP15 CM were combined (Figs. 1 and 2B) . A summary of the forms of BMP15 and GDF9 secreted into CM, and the noncovalent interactions identified between these forms, is presented in Table 1 and Figure 3 .
Mouse BMP15 and mGDF9 Cooperate with SpeciesSpecific Interactions
A rat granulosa cell thymidine-incorporation bioassay was used to determine the bioactivities of mouse and ovine BMP15 and GDF9, alone and in all four combinations (Fig. 4A) . Preliminary dose-response studies (data not shown) ascertained that 6 ng/ml BMP15 and 25 ng/ml GDF9 were optimal to show cooperative bioactivity without interference from components of 293H cell culture media. At these concentrations, none of the CM containing each growth factor alone was active in the bioassay. However, when BMP15 and GDF9 were combined, thymidine incorporation increased ;7-fold above that of control 293H cell CM (n ¼ 4 pools, P , 0.05). Mouse BMP15 also acted cooperatively with ovine GDF9 (n ¼ 4 pools, P , 0.05). To investigate the role of species in cooperative interactions between BMP15 and GDF9, combined CM were treated with mab47B that was made against a region of GDF9 mature protein fully conserved in both mice and sheep (Fig.  4A) . When ovine GDF9 was added to either species of BMP15 and treated with mab47B, the entire cooperative bioactivity was abolished to a level not different from the control 293H CM (n ¼ 4 pools, P , 0.05). However, when mouse GDF9 CM was added to either species of BMP15, approximately half the cooperative bioactivity was abolished, and the stimulation was still significantly different from control 293H CM (n ¼ 4 pools, 
BMP15 PROREGION REGULATES COOPERATIVITY WITH GDF9
P , 0.05). This was not due to insufficient antibody, since the same amount of antibody was able to reduce bioactivity of 250 ng/ml mouse GDF9 (i.e., 10 times the original concentration) to a level not significantly different than control 293H CM ( Fig.  4B ; n ¼ 3 pools, P , 0.05).
Mouse BMP15 and GDF9 Act Cooperatively via BMPR2 and ACVR1B/TGFBR1/ACVR1C Receptors
To characterize the signaling pathways activated by cooperative interactions between mouse BMP15 and GDF9, combined CM were first treated with a dimer of the extracellular region of BMPR2, the type 2 receptor for both BMP15 and GDF9 (Fig. 5A) . Addition of BMPR2 inhibited thymidine incorporation by rat granulosa cells to levels that were not different from cells treated with control 293H CM alone (n ¼ 4 pools, P , 0.05). Combined CM were then treated with SB431542, an inhibitor of ACVR1B/TGFBR1/ACVR1C, and tested for thymidine incorporation activity (Fig. 5B) . Granulosa cells treated with Activin A or any species combination of BMP15 and GDF9 were found to be inhibited by SB431542 (n ¼ 3 pools, P , 0.05). However, the bioactivity of cells treated with BMP4 or 293H control media was also inhibited. This background inhibition was found not to be caused by cell death (CellTitre 96 Aqueous One; In Vitro Technologies; n ¼ 2 pools, results not shown). Together, these results suggest that there is an endogenous TGF-beta-like activity operating in rat granulosa cells that may account for the inhibition of BMP4 bioactivity by the inhibitor. It is also possible that BMP4 triggers a downstream TGF-beta-like activity operating through a pathway inhibited by SB431542. Nevertheless, it is important to note that BMP4 inhibition is significantly different than that observed for all combinations of BMP15 and GDF9, suggesting that BMP15 and GDF9 do act cooperatively via this pathway.
FIG. 3. Secreted forms of recombinant mouse GDF9 and BMP15
identified by coimmunoprecipitation and chemical cross-linking. Dimers of GDF9 and monomeric forms of BMP15 mature, proregion, and uncleaved promature proteins were identified, as were non-covalently associated forms of BMP15 proregion/BMP15 mature protein, GDF9 proregion/GDF9 mature protein, and BMP15 proregion/GDF9 mature protein. It is not known whether the proregion/mature protein associations (*) are direct or mediated by other proteins, including other BMP15 and GDF9 forms. Combinations of CM containing mouse and ovine BMP15 (mB and oB, respectively, each 6 ng/ ml) and GDF9 (mG and oG, respectively, each 25 ng/ml) were tested for immunoneutralization of thymidine incorporation activity by mab47B (47B; anti-GDF9 mature protein), with no antibody (-), and IgG as controls (n ¼ 4 pools, means marked with different letters are significantly different, P , 0.05). B) The ability of mab47B to immunoneutralize the thymidine incorporation bioactivity of a 10-times-higher concentration of mouse GDF9 (i.e., 250 ng/ml) was tested (n ¼ 3 pools, ''a'' represents significant difference to ''b,'' P , 0.05).
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Immunoneutralization by Mouse BMP15 Proregion Antibody
The role of proregion interaction on the cooperative bioactivity of BMP15 and GDF9 was then investigated by testing the ability of proregion antibodies to immunoneutralize combined CM bioactivity (Fig. 6 ). An antibody made against the mouse BMP15 proregion was able to inhibit (P , 0.05) cooperative thymidine incorporation activity of mouse BMP15 and GDF9 to a level not significantly different to 293H control CM (n ¼ 3 pools, P , 0.05). In contrast, there was no change when combined CM were treated with mouse GDF9 proregion antibody.
DISCUSSION
Following the identification of BMP15 and GDF9, the use of recombinant BMP15 and GDF9 proteins has been invaluable in characterizing the bioactivity and function of these growth factors. However, the forms that are secreted have not been confirmed, and in particular, the ability of BMP15 to be secreted at all in the mouse has been challenged [38] . Here we report that mouse BMP15 and GDF9 are both secreted by transfected 293H cells as cleaved mature proteins and proregions of BMP15 and GDF9 and uncleaved BMP15 promature protein. This is similar to a recent report showing that recombinant human BMP15 proregion and uncleaved promature proteins are secreted with the human BMP15 mature protein [42] . Interestingly, we did not identify secreted, uncleaved mouse GDF9 promature protein. Previously, both ovine BMP15 and GDF9 produced by transfected 293H cells were also almost fully processed into mature protein monomers or dimers, respectively [43] . However, in ovine follicular fluid BMP15 and GDF9 were detected as mostly uncleaved promature proteins [44] . Therefore, it is possible that 293H cells may process BMP15 and GDF9 more effectively into cleaved mature and proregion proteins than occurs in physiological fluids, and that this processing differs between species. Whether cleavage is carried out in 293H cells by different enzymes or by a single enzyme with different cleaving affinities for BMP15 and GDF9 is not yet known. Moreover, it is also not known whether this is similar to what may occur in vivo.
Using specific proregion antibodies for immunoprecipitation, it was evident that the mature regions of mouse BMP15 and GDF9 interact noncovalently with their respective proregions in CM containing either BMP15 or GDF9 alone or in combination. Additionally, GDF9 mature protein was found to coimmunoprecipitate with the proregion of BMP15, either through a direct interaction or indirectly via other proteins, importantly providing evidence for the existence of BMP15/GDF9 heteromers. Previously, human BMP15 was reported to form mature homodimers, multimers, and heterodimers with GDF9 mature proteins, but no comment was made as to proregion involvement [22] . In another study in sheep, only GDF9 was reported to form mature dimers, with both BMP15 and GDF9 forming larger multimers. However, there was no indication of heteromeric interaction between these two ovine proteins [43] .
Using chemical cross-linking, we have shown that mouse GDF9 formed mostly mature protein homodimers with or without BMP15, as well as some multimers that included GDF9 mature regions and proregions. In contrast, mouse BMP15 did not form mature homodimers but instead was present in CM as monomeric proregion, mature and uncleaved promature proteins, and some multimers. When BMP15 was combined with GDF9, additional multimers larger than 66 M r 3 10 À3 were formed, and these multimers included proregions and mature proteins of both BMP15 and GDF9. These interactions were duplicated when we cross-linked CM from 293H cells cotransfected with both BMP15 and GDF9 (McIntosh, Lawrence, Juengel, and McNatty, unpublished data). Taking the coimmunoprecipitation and cross-linking results together, we propose that the heteromeric BMP15 proregion/GDF9 mature interactions, and also the BMP15 proregion/BMP15 mature and GDF9 proregion/GDF9 mature interactions, occur as part of multimeric complexes (Fig. 3) . 6 . Immunoneutralization with proregion antibodies. CM for mouse BMP15, GDF9, and combined BMP15 and GDF9 were treated with no antibody (-), KLH antibody, GDF9 proregion antibody (GDF9), BMP15 proregion antibody (BMP15), and combined BMP15 proregion and GDF9 proregion antibodies (BþG). Thymidine incorporation bioactivity of rat granulosa cells with these treatments was compared (6SEM) to activity of cells treated with 293H control CM (n ¼ 3 pools, means marked ''a'' are significantly different from the 293H control CM mean of 1.00, P , 0.05).
BMP15 PROREGION REGULATES COOPERATIVITY WITH GDF9
Monomeric BMP15 forms, dimeric GDF9, and other binding proteins may also be involved in these complexes.
We also report that recombinant mouse BMP15 cooperates with mouse or ovine GDF9 at low concentrations in a thymidine incorporation bioassay, as has been previously shown for ovine BMP15 and ovine or mouse GDF9 [16, 17] . Neutralization of this cooperativity with a GDF9 antibody made against a mature peptide sequence fully conserved for both mice and sheep identifies a species difference in the way this antibody is able to interfere with the cooperative interactions existing between BMP15 and GDF9. It is likely that a species difference in the molecular mechanism of cooperativity exists, as species of BMP15 and GDF9 have previously been shown to determine response for thymidine incorporation, as well as inhibin and progesterone production, in granulosa cells from several species [16, 17] . As has been shown for BMP15/GDF9 cooperativity in sheep [43] , we found that BMPR2 and one or more of the type 1 ACVR1B/ TGFBR1/ACVR1C receptors (also known as ALK4,5,7) is the receptor combination through which mouse BMP15 and GDF9 signal cooperatively for thymidine uptake. This is also the combination of receptors, i.e., a BMP type 2 receptor and a TGF-beta/activin type I receptor, through which GDF9 alone signals [45] . A further immunoneutralization experiment using proregion antibodies provides compelling evidence that the mouse BMP15 proregion is involved in the cooperative bioactivity of BMP15 with GDF9. While the mouse GDF9 proregion antibody utilized in this study did not inhibit cooperative bioactivity, investigation of antibodies made against other GDF9 proregion peptides will be needed before GDF9 proregion involvement can be ruled out.
There are several possible ways in which the proregion could function to explain our immunoneutralization results. Proregion interaction may modulate the mature region prior to receptor binding so that the immunoneutralizing antibody prevents receptor binding. The proregion may facilitate formation and stability of a heteromer that might be required prior to receptor binding. It is also possible that activity of a proregion-mature region hetero-multimeric complex bound to a receptor is up-regulated by the BMP15 proregion in some way. Several TGF-beta family proteins are already known to be regulated by noncovalent interaction with their proregions after secretion. Homodimers of TGF-beta isoforms 1, 2, and 3 are inhibited by a noncovalent association with a proregion homodimer, with or without other binding proteins [29] . Myostatin also exists in a latent complex of non-covalently bound mature protein, proregion, and other binding proteins that must dissociate to release mature protein for up-regulation of skeletal muscle growth [31, 32] . Mouse nodal protein employs proregion-mature interaction to both inhibit and stabilize mature nodal protein. Without the proregion, the mature protein is rapidly cleared via receptor-mediated endocytosis and degraded intracellularly, unless protected by N-linked glycosylation to allow exocytotic recycling [30] . In contrast, the bioactivity of anti-Mullerian hormone/Mullerian inhibiting substance is enhanced by proregion interaction with the mature protein [33] . Together these and other examples [46, 47] show that the proregions of some TGF-beta family proteins are capable of a range of regulatory mechanisms. Phenotypes resulting from natural mutations in the BMP15 proregion of sheep [44] and women [34] [35] [36] [37] 48] may be explained by lack of appropriately processed mature protein being produced, impaired regulation by the proregion, or a combination of both these effects.
The interplay between BMP15 and GDF9 has been studied by several groups using unpurified, transfected mammalian cell CM, purified recombinant proteins, or denuded oocytes, but these studies have yielded apparently conflicting results [49] [50] [51] . A cooperative participation between BMP15 and GDF9, where both growth factors are required but neither alone is sufficient, may help to explain these discrepancies. Given our findings of noncovalent interactions between proregion and mature protein, there are several challenges to finding preparations of recombinant BMP15 and GDF9 that will reveal definitive information about the in vivo situation. Conditioned media contains many proteins other than the recombinant protein of interest, either from media components or secreted by the transfected cells, that may be inhibitory or stimulatory. However, CM purification methods may not only remove the several proteins that could interfere with the bioassays, but also may remove protein forms of BMP15 and GDF9 important to bioactivity and cooperativity, such as the proregion. A major focus of BMP15/GDF9 research at present is to better understand the mechanisms supporting oocyte developmental competence, in order to allow optimal clinical oocyte maturation that enables preimplantation, embryo development, and full development to term. Currently, in vitro maturation (IVM) conditions for oocytes are suboptimal, but supplementation of IVM media with oocyte-secreted factors has recently shown promising results [52] .
In summary, we have shown that recombinant mouse BMP15 and GDF9 are able to be secreted by transfected 293H cells in multiple protein forms. Both BMP15 and GDF9 formed multimers, but while GDF9 also formed mature homodimers, BMP15 was observed as monomeric proregion, mature, and promature protein forms, with a notable absence of mature homodimers. Our identification of homomeric proregion/ mature protein interactions, and importantly a heteromeric BMP15 proregion/GDF9 mature protein interaction, supports a model where mouse BMP15/GDF9 cooperativity occurs at a multimeric rather than a dimeric level. We have shown that these cooperative interactions are species-specific and signal for thymidine incorporation via BMPR2 and the ACVR1B/ TGFBR1/ACVR1C receptor-mediated pathways. The ability of a BMP15 proregion antibody to immunoneutralize BMP15/ GDF9 cooperativity reveals a novel and potentially key role for the BMP15 proregion. Further knowledge of the interacting forms of BMP15 and GDF9 secreted by the oocyte and the responses these forms elicit within the follicle should in the future not only allow oocyte IVM to be performed under optimal, near-physiological conditions, but will also provide the tools to modulate oocyte development in a much wider set of in vivo applications.
